文献リスト

1) Morris CM, Pardo-Villamizar C, Gause CD, et al. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci. 2009; 276: 45-8

2) Freeman RD, Zinner SH, Müller-Vahl KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009; 51: 218-27

3) Mol Debes NM, Hjalgrim H, Skov L. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome. J Child Neurol. 2008; 23: 1017-27

4) Kano Y, Ohta M, Nagai Y, et al. Association between Tourette syndrome and comorbidities in Japan. Brain Dev. 2010; 32: 201-7

5) Kano Y, Kono T, Shishikura K, et al. Obsessive-compulsive symptom dimensions in Japanese tourette syndrome subjects. CNS Spectr. 2010; 15: 296-303

6) Haddad AD, Umoh G, Bhatia V, et al. Adults with Touretteʼs syndrome with and without attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2009; 120: 299-307

7) Burd L, Li Q, Kerbeshian J, et al. Tourette syndrome and comorbid pervasive developmental disorders. J Child Neurol. 2009; 24: 170-5

8) Kerbeshian J, Peng CZ, Burd L. Tourette syndrome and comorbid early-onset schizophrenia. J Psychosom Res. 2009; 67: 515-23

9) Cutler D, Murphy T, Gilmour J, et al. The quality of life of young people with Tourette syndrome. Child Care Health Dev. 2009; 35: 496-504

10) Bernard BA, Stebbins GT, Siegel S, et al. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord. 2009; 24: 1070-3

11) Müller-Vahl K, Dodel I, Müller N, et al. Health-related quality of life in patients with Gilles de la Touretteʼs syndrome. Mov Disord. 2010; 25: 309-14

12) Pringsheim T, Lang A, Kurlan R, et al. Understanding disability in Tourette syndrome. Dev Med Child Neurol. 2009; 51: 468-72

13) Gorman DA, Thompson N, Plessen KJ, et al. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry. 2010; 197: 36-44

14) Debes N, Hjalgrim H, Skov L. The presence of attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder worsen psychosocial and educational problems in Tourette syndrome. J Child Neurol. 2010; 25: 171-81

15) Altman G, Staley JD, Wener P. Children with Tourette disorder: a follow-up study in adulthood. J Nerv Ment Dis. 2009; 197: 305-10

16) Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008; 65: 461-72

17) Centers for Disease Control and Prevention (CDC). Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep. 2009; 58: 581-5

18) Eichele H, Eichele T, Hammar A, et al. Go/NoGo performance in boys with Tourette syndrome. Child Neuropsychol. 2010; 16: 162-8

19) Thibault G, OʼConnor KP, Stip E, et al. Electrophysiological manifestations of stimulus evaluation, response inhibition and motor processing in Tourette syndrome patients. Psychiatry Res. 2009; 167: 202-20

20) Franzkowiak S, Pollok B, Biermann-Ruben K, et al. Altered pattern of motor cortical activation-inhibition during voluntary movements in Tourette syndrome. Mov Disord. 2010 Jul 28. [Epub ahead of print]

21) Heise KF, Steven B, Liuzzi G, et al. Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome. Brain. 2010; 133: 580-90

22) Roessner V, Overlack S, Baudewig J, et al. No brain structure abnormalities in boys with Touretteʼs syndrome: a voxel-based morphometry study. Mov Disord. 2009; 24: 2398-403

23) Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res. 2009; 67: 559-73

24) Fahim C, Yoon U, Das S, et al. Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex. 2010; 46: 750-60

25) Müller-Vahl KR, Kaufmann J, Grosskreutz J, et al. Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci. 2009; 10: 47

26) Fahim C, Yoon U, Sandor P, et al. Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome. Brain Topogr. 2009; 22: 176-84

27) Ludolph AG, Pinkhardt EH, Tebartz van Elst L, et al. Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity？ Dev Med Child Neurol. 2008; 50: 524-9

28) Tobe RH, Bansal R, Xu D, et al. Cerebellar morphology in Tourette syndrome and obsessive-compulsive disorder. Ann Neurol. 2010; 67: 479-87

29) Govindan RM, Makki MI, Wilson BJ, et al. Abnormal water diffusivity in corticostriatal projections in children with Tourette syndrome. Hum Brain Mapp. 2010 Feb 16. [Epub ahead of print]

30) Makki MI, Govindan RM, Wilson BJ, et al. Altered fronto-striato-thalamic connectivity in children with Tourette syndrome assessed with diffusion tensor MRI and probabilistic fiber tracking. J Child Neurol. 2009; 24: 669-78

31) Thomalla G, Siebner HR, Jonas M, et al. Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain. 2009; 132: 765-77

32) Neuner I, Kupriyanova Y, Stöcker T, et al. White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage. 2010; 51: 1184-93

33) Cavanna AE, Stecco A, Rickards H, et al. Corpus callosum abnormalities in Tourette syndrome: an MRI-DTI study of monozygotic twins. J Neurol Neurosurg Psychiatry. 2010; 81: 533-5

34) Mazzone L, Yu S, Blair C, et al. An FMRI study of frontostriatal circuits during the inhibition of eye blinking in persons with Tourette syndrome. Am J Psychiatry. 2010; 167: 341-9

35) Raz A, Zhu H, Yu S, et al. Neural substrates of self-regulatory control in children and adults with Tourette syndrome. Can J Psychiatry. 2009; 54: 579-88

36) Church JA, Fair DA, Dosenbach NU, et al. Control networks in paediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain. 2009; 132: 225-38

37) Albin RL, Koeppe RA, Wernette K, et al. Striatal [11C]dihydrotetrabenazine and [11C]methylpheniate binding in Tourette syndrome. Neurology. 2009; 72: 1390-6

38) Steeves TD, Ko JH, Kideckel DM, et al. Extrastriatal dopaminergic dysfunction in tourette syndrome. Ann Neurol. 2010; 67: 170-81

39) Saporta AS, Chugani HT, Juhász C, et al. Multimodality neuroimaging in Tourette syndrome: alpha-[11C] methyl-L-tryptophan positron emission tomography and diffusion tensor imaging studies. J Child Neurol. 2010; 25: 336-42

40) Breedveld GJ, Fabbrini G, Oostra BA, et al. Tourette disorder spectrum maps to chromosome 14q31. 1 in an Italian kindred. Neurogenetics. 2010 May 2. [Epub ahead of print]

41) Knight S, Coon H, Johnson M, et al. Tourette Syndrome Association International Consortium for Genetics. Linkage analysis of Tourette syndrome in a large Utah pedigree. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B: 656-62

42) Zimprich A, Hatala K, Riederer F, et al. Sequence analysis of the complete SLITRK1 gene in Austrian patients with Touretteʼs disorder. Psychiatr Genet. 2008; 18: 308-9

43) Herzberg I, Valencia-Duarte AV, Kay VA, et al. Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate. Psychiatr Genet. 2010; 20: 179-83

44) Dehning S, Müller N, Matz J, et al. A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome. Psychiatr Genet. 2010; 20: 35-8

45) Ercan-Sencicek AG, Stillman AA, Ghosh AK, et al. L-histidine decarboxylase and Touretteʼs syndrome. N Engl J Med. 2010; 362: 1901-8

46) Chou IC, Lin HC, Wang CH, et al. Polymorphisms of interleukin 1 gene IL1RN are associated with Tourette syndrome. Pediatr Neurol. 2010; 42: 320-4

47) Sundaram SK, Huq AM, Wilson BJ, et al. Tourette syndrome is associated with recurrent exonic copy number variants. Neurology. 2010; 74: 1583-90

48) Budman C, Coffey BJ, Shechter R, et al. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol. 2008; 18: 509-15

49) Lyon GJ, Samar S, Jummani R, et al. Aripiprazole in children and adolescents with Touretteʼs disorder: an open-label safety and tolerability study. J Child Adolesc Psychopharmacol. 2009; 19: 623-33

50) Kawohl W, Schneider F, Vernaleken I, et al. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. World J Biol Psychiatry. 2009; 10: 827-31

51) McCracken JT, Suddath R, Chang S, et al. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol. 2008; 18: 501-8

52) Pringsheim T, Marras C. Pimozide for tics in Touretteʼs syndrome. Cochrane Database Syst Rev. 2009; (2): CD006996

53) Ho CS, Chen HJ, Chiu NC, et al. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc. 2009; 108: 788-93

54) Kuo SH, Jimenez-Shahed J. Topiramate in treatment of tourette syndrome. Clin Neuropharmacol. 2010; 33: 32-4

55) Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010; 81: 70-3

56) Fernández-Jaén A, Fernández-Mayoralas DM, Muñoz-Jareño N, et al. An open-label, prospec-tive study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol. 2009; 13: 541-5

57) Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol. 2009; 40: 420-5

58) Zhao L, Li AY, Lv H, et al. Traditional Chinese medicine Ningdong granule: the beneficial effects in Touretteʼs disorder. J Int Med Res. 2010; 38: 169-75

59) Porta M, Sassi M, Ali F, et al. Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective. J Psychosom Res. 2009; 67: 585-90

60) Welter ML, Mallet L, Houeto JL, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008; 65: 952-7

61) Ackermans L, Duits A, Temel Y, et al. Long-term outcome of thalamic deep brain stimulation in two patients with Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 Jul 26. [Epub ahead of print]

62) Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010; 303: 1929-37

63) Woods DW, Walther MR, Bauer CC, et al. The development of stimulus control over tics: a potential explanation for contextually-based variability in the symptoms of Tourette syndrome. Behav Res Ther. 2009; 47: 41-7

64) Sukhodolsky DG, Vitulano LA, Carroll DH, et al. Randomized trial of anger control training for adolescents with Touretteʼs syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry. 2009; 48: 413-21

65) Nagai Y, Cavanna A, Critchley HD. Influence of sympathetic autonomic arousal on tics: implications for a therapeutic behavioral intervention for Tourette syndrome. J Psychosom Res. 2009; 67: 599-605

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp